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CHAPTER 1: INTRODUCTION
1.1 Alzheimer’s Disease(AD)
Alzheimer’s disease is a progressive neurodegenerative disease that includes symptoms such as
memory loss, language deterioration which were discovered by Alois Alzheimer and his contemporaries.
AD is one of the sixth leading cause for death in United states and fifth leading cause of death in Americans
who are 65 years or older. The aggregation of B-amyloid plaques in the brain is the main characteristic of
AD. Neuropathologically, AD is characterized by the presence of senile plaques, neurofibrillary tangles,
persistent neuronal loss, although, the neurotoxic mechanisms have not been completely elucidated. Both
oxidative stress and inflammation play a key role in the illness[1]. AD is often preceded by three stages of
progression characterized by gradual increase of neuropathological hallmarks (SP and NFT) starting from
preclinical AD (PCAD) to amnestic mild cognitive impairment (MCI) and early AD (EAD)[2]. Several
hypotheses have been put forward on the basis of the various causative factors in order to explain this
multifactorial disorder[3] such as the cholinergic hypothesis, Aβ hypothesis, tau hypothesis and
inflammation hypothesis[4]. Currently there is no specific treatment for Alzheimer’s Disease. Identifying
quantifiable markers of disease—whether by neuroimaging, CSF, or blood markers—has the potential (a)
to allow for early identification of possibly presymptomatic subjects at risk for developing AD and (b) to
provide measures by which disease severity and progression may be evaluated; thus, such biomarkers may
be invaluable in providing endpoints (or objective milestones) for clinical therapeutic trials[5]. There are
different types of fluid biomarkers such as CSF-based biomarker and blood plasma based biomarkers which
are used in the investigation of AD. A study by Ray S., et al., in 2007 proposed plasma biomarkers as an
alternative to CSF biomarkers for the early detection of AD. The naturally occurring anti-inflammatory and
anti-oxidant compounds including curcumin are currently under investigation. There are some diet related
disorders such as hypercholesterolemia, diabetes, etc., which are also correlated to AD[6]. Many studies
have recommended a positive connection between AD and the consumption of diet low in antioxidants[7].
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Fig 1: Amyloid plaques and neurofibrillary tangles spread through the brain as the disease progresses[6].
1.2 Oxidative stress
Numerous studies demonstrate that different biomarkers of oxidative-stress-mediated events are
elevated in the AD brain. Studies in animal models of the disease with antioxidants report significant
improvements of their AD-like phenotype [9]. Under normal conditions, damage by oxygen radicals is kept
in check by an efficient array of antioxidant systems that display extensive redundancy (e.g. the
simultaneous metabolism of H2O2 by catalase and glutathione peroxidase). However, during pathological
conditions, the oxidant versus antioxidant balance is necessarily altered, either primarily or secondarily.
Oxidative damage occurs when the oxidative balance is disturbed such that reactive oxygen production
exceeds cellular anti-oxidant defenses. The oxidative damage found in AD includes advanced glycation
end products [1,4], nitration [5,6], lipid peroxidation adduction products [7,8], carbonyl-modified
neurofilament protein and free carbonyls [9,11]. Oxidative stress has been associated with the onset and
progression of mild cognitive impairment (MCI) and Alzheimer disease (AD). AD and MCI brain and
plasma display extensive oxidative stress as indexed by protein oxidation, lipid peroxidation, free radical
formation, DNA oxidation, and decreased antioxidants.[10]
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Fig 2: Oxidative stress in Alzheimer’s Disease[9]

1.3 Oil Palm Phenolics (OPP)
Diets containing high amounts of phytochemicals can give security against free radical-induced
diseases, because of their high cell reinforcement activities. Oil palm phenolics (OPP) is a complex fluid
derived from plant which for the most part includes polyphenol mixes, shikimic acid, oligosaccharides, and
lipid. Likewise, gallic acid, protocatechuic acid, p-hydroxybenzoic acid, vanillic acid, caffeic acid, syringic
acid, p-coumaric acid and ferulic acid are additionally nearness in OPP through superior fluid
chromatography (HPLC), fluid chromatography-pair mass spectrometry (LS/MS/MS) investigations.
Although the fruits of oil palm are mainly used for extraction of eatable oils, successful recuperation from
the aqueous by-products following palm oil generation has recognized a water soluble complex rich in
phenolics and natural acids altogether alluded as Oil Palm Phenolics. Plant phenolics are imperative
antioxidants because of their high redox potential, which allows them to go about as reducing agents,
hydrogen donors, singlet oxygen quenchers, and metal chelators. Antioxidants that gather in neuronal
tissues are potential candidates for the anticipation and treatment of neuronal disorders involving oxidative
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stress. Phenolic antioxidants might possibly cross the brain barrier, depending on their properties, such as
charged state, lipophilicity, and interactions with efflux transporters, with possible relative specificity of
the compounds for various brain areas. Numerous current studies have shown that plant phenolics have
neuroprotective effects, through their capacity to decrease oxidative stress. Notwithstanding their cell
reinforcement activities, plant phenolic compounds such as flavonoids have been shown to possess other
atomic mechanisms [11]. Since AD and the associated amyloid plaque development has an underlying part
of oxidative stress, we hypothesized that OPP may decrease amyloid beta weight in vivo. In a previous pilot
study we discovered OPP would decrease be able to the β amyloid in the cell culture, it is necessary for us
to start a further investigation on its impact by using a creature demonstrate with AD.

Fig 3: Main compounds of Oil Palm Phenolics[12]

1.4 Curcumin
Curcumin is extracted from the herb Curcuma Longa, more generally known as turmeric, a sterile
plant. Formally recognized as diferuloylmethane, curcumin was first characterized in 1815, and its
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crystalline shape was first acquired in 1870. For quite a long time, it was as often as possible utilized as a
characteristic plant item in Ayurveda, an Indian arrangement of all-encompassing pharmaceutical, to treat
inflammation, liver disorders, diabetic wounds, and Sinusitis. Its utilization has now extended past
restorative purposes to numerous items and substances over the world, including curry, mustard, bandhelps, cheddar, and spread[13]. Curcumin is a substance that is delicate to debasement by visible and
ultraviolet light, and additionally high pH and oxygen, having a half-existence of around 8 hours in human
blood[14]. The structure of curcumin is made from a carbon chain connecting two aryl gatherings. Scientists
have discovered the phenolic OH bunches connected to the aryl gatherings to have the capacity to scavenge
reactive oxygen species (ROS), adding to its hostile to oxidative impact. Moreover, curcumin was appeared
to associate with various substances including DNA, lipids, and proteins[15]. The expanding measure of
writing over Curcumin demonstrates adaptable uses of Curcumin's properties. Curcumin has been appeared
to restrain various pathways required in apoptosis and cell invasion, exerts potent antioxidant effects, and
influences catalysts that control tumor movement. In fact, explore has been done on the effects of curcumin
for different therapeutic uses, and researchers have discovered potential parts of curcumin in restraint of
invasion by thyroid disease cells, effort of defensive effects against alcohol instigated lethality, and aversion
of bosom tumor, among different employments[16]. Curcumin's capacity to cross the blood-brain barrier
(BBB) is basic to its improvement as a neuroprotective operator. In spite of the fact that it has been
suggested that the capacity of dietary curcumin to manage the cost of neuroprotection in preclinical animal
models of neurodegenerative diseases is proving its capacity to cross the BBB, this matter requires
significant investigation[17].

Fig 4: Structure of Curcumin
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1.4.1

Curcumin for Alzheimer’s Disease:
Given the significance of β-amyloid amassing in the pathogenesis of AD, numerous in vitro and in

vivo studies have examined the interaction of curcumin with β-amyloid. Several studies have investigated
the dose-related neuroprotective impact of curcumin against β-amyloid-induced danger in refined neuronal
cells[1, 17, 18]. Curcumin may also influence the creation and deposition of β-amyloid, long idea to be one
of the triggers for neurodegeneration in AD. In both rodent cortical neurons and in solution, curcumin
created a dose-subordinate decrease in arrangement of fibrillary β-amyloid1–40 and β-amyloid1–42 and
furthermore destabilized fibrils that had effectively framed, thus breaking up the β-sheet adaptation seen in
AD plaques[18]. Based on the various findings support the benefits of its oral intake, it is trusted that
curcumin will prompt a promising treatment for Alzheimer's disease. In this way, we included curcumin in
our trial elevated cholesterol eating regimen to serve as a positive control, which enables us to compare it
and our testing supplement OPP in their helpful effects and potential mechanisms.

Fig 5: Different mechanisms of Curcumin in Alzheimer’s Disease[19].
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1.5

Metabolomics:
Metabolomics alludes to worldwide examination of small molecular weight molecules or
metabolites in body fluids, for example, urine and plasma serum. Metabolites are intermediates or results
from metabolism and are included in typical development, advancement and multiplication through
different metabolic pathways. The human serum metabolome comprises of 4200 unique mixes while the
human CSF contains almost 500 distinct metabolites. These metabolites can be lipids, amino acids, glucose
or intermediates of digestion[20]. Metabolome is alluded to the gathering of metabolites at the season of
testing. Distinguishing proof of the subsequent metabolic examples in biological fluids is viewed as
metabolic profiling. Metabonomics ordinarily alludes to the estimation of changes in a life form's metabolic
profile because of external stimuli, genetic modification or as an outcome of the nearness of illness.
Metabolic profiling gives an exhaustive perspective of the physiology of that cell around then. Metabolites
are included in all the cell exercises, for example, cell signaling, vitality exchange and correspondence.
Metabolites are the downstream aftereffect of genetic translation forms and, all the while, reflect natural
and way of life considers and in addition singular attributes identified with dietary reaction and gut
microflora[21]. Researchers of the college of Alberta and the college of Calgary finished the primary draft
of the human metabolome in January 2007; they have recorded around 2500 metabolites, around 1200
medications and 3500 sustenance segments which can be found in the human body. Metabolome is the
gathering of all metabolites in the cell and human body contains trillions of cells so there may be the same
number of little metabolomes, all can be not the same as each other.
1.6 Metabolomics and Metabonomics:
Metabonomics is the term given by Dr. Nicholson and his associates in 1996 to depict the
metabolite profiling in biofluids. All in all, Metabonomics allude to the term used to depict an approach of
concentrate all cell metabolome at one time. As per Dr. John Lindon Metabonomics term supplements
genomics and proteomics.
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Term metabolomics has more noteworthy similitude to metabolite and is more boundless at NIH and
subsidiary researchers. As indicated by Nicholson this can be viewed as subset of Metabonomics and it
covers ordering tests, understanding biochemical systems, distinguishing biomarkers, quantitatively
breaking down fixations and fluxes and examining atomic flow and association[22]
1.7 Techniques and approaches for data acquisition:
As portrayed over, one of the goals of metabolomics in the pharmaceutical field is to recognize and
evaluate particular metabolic markers defenseless to enhance quality control, enhance early conclusion,
review restorative results and encourage the improvement of novel medications competitors[23]. The
system depends on differential metabolic expression profiling. There are two general methodologies, target
particular and worldwide or non-coordinated, for metabolomic biomarker disclosure. Target-particular or
science driven, an approach habitually utilizes mass spectrometry and is utilized for approval and routine
clinical examination. The major systems utilized for this approach incorporate Nuclear Magnetic Resonance
(1H NMR) spectroscopy, Gas chromatography-mass spectrometry (GC-MS), Liquid chromatography-mass
spectrometry (LC-MS). Barely any different procedures are additionally utilized for information obtaining
including Fourier transformed infrared (FT-IR) spectrometry, high-performance liquid chromatography
(HPLC) or capillary electrophoresis. Worldwide/non-directed methodologies may have more potential for
biomarker disclosure since they are unprejudiced. They enable the concurrent assessment of hundreds to
thousands metabolites in a visually impaired way without from the earlier expanding the potential number
of hopeful biomarkers[24].
1.8 NMR Spectroscopy:
NMR Spectroscopy has been utilized for deciding the structures of natural compound for as far
back as fifty years. It is a noninvasive and financially savvy method. Test measure required for NMR
spectroscopy is generally bigger than those required for mass spectroscopy[25]. The foremost behind this
scientific instrument utilizes attractive properties of a few cores. The atoms with an odd number of protons
or neutrons have the attractive minute. Ordinarily, C-13 and H-1 are utilized for measuring reverberation
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however other cores can likewise be utilized. Attractive cores, when subjected to attractive field particular
to those cores, can ingest radio recurrence. Because of this absorbance, the cores are in reverberation state.
These reverberation frequencies are distinctive for various particles and iotas inside atoms and this gives
the auxiliary data about the particle. Two sorts of techniques are utilized ordinarily to get proton NMR
spectra. One is called consistent wave strategy and the other is beat Fourier change system. In nonstop wave
strategy, the example is put between the posts of an effective magnet and is spun while differing the
attractive field quality. Proper radiofrequency is connected through the receiving wire curl and the
reverberation of assimilated vitality is gotten by the beneficiary loop and recorded by an electronic gadget
associated with the PC. Each synthetically unique proton in an example, when set in a solid attractive field
will display a particular compound move which relies on upon the centralization of the proton in a particular
domain. The distinctive metabolites will have protons in a synthetically unique condition and consequently
will deliver the signs at various compound move esteems in the NMR range. Range can be dissected by
doling out compound move to the metabolites and after that looking at them between the gatherings. In
pulse Fourier change technique, the attractive field is kept consistent and the radio recurrence radiation of
fluctuating recurrence is connected. The reverberation is recorded through the same route by beneficiary
curl as in persistent wave technique. If there should be an occurrence of heartbeat Fourier change technique,
a mind-boggling covering reverberation is gained in time-recurrence space known as free acceptance
decay(FID) arrangement and after that these FID records are prepared to the recurrence area customary
range by Fourier change. This range gives data on the number and kind of substance elements in a particle.
Fourier change technique was used in this examination for assessment of contrasts in metabolomic profiles
in

atherogenic

eat

less

carbs

actuated

rodent

model

of

Alzheimer's

(Joseph

Hornak,

www.cem.msu.edu/~reusch).
1.9 Metabolomics and Alzheimer’s Disease:
Metabolomics of biological fluids followed by multivariate analysis of the spectroscopic data is a
systems biological approach that has been used to identify important changes in metabolism. NMR
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metabolomics of transgenic AD mice model was used to identify and characterize small molecules that are
changed in the urine levels during the AD development. Levels of 3-hydroxykynurenine, homogentisate
and allantoin were significantly higher compared to control mice in the stage prior to AD symptoms and
reverted to control values by early/middle stage of AD. The level of these changed metabolites at very early
period may provide an indication of disease risk at asymptomatic stage[26].

11
Hypothesis:
The Oil Palm Phenolics (OPP) have shown anti oxidative and anti-inflammatory effects on Alzheimer’s
Disease. Wu Yan et al., demonstrated that dietary OPP has potential in enhancing an age-related decrease
in spatial cognizance and Aß deposition in the hippocampus[27]. Therefore, we hypothesized, atherogenic
diet (2% cholesterol) will elicit the AD neurotic changes in aging rats, and OPP will slow down the process
by antioxidant & anti-inflammatory effects, which will be reflected in regulation of plasma biomarkers and
pathways involved in AD.
We used Curcumin as a positive control and its impact on AD will be analyzed too in this examination. The
accompanying specific aims were proposed to meet our theory
Specific Aim 1A: To investigate differences in plasma metabolomic profiles of Atherogenic Diet Induced
Rat Model of Alzheimer’s Disease (AD) and treatment with dietary OPP/ curcumin in Control (C), High
cholesterol (H), High cholesterol + 5% OPP (HP) and High cholesterol + 2% curcumin (HC). To determine
the correlations between the plasma metabolomic profiles and oxidative and inflammatory markers;
Specific Aim 1B: To identify and quantify metabolites responsible for the differences in Metabolomic
Profiles of Control and treated groups.
Specific Aim 1C: To study the correlation of inflammatory markers and oxidative stress markers with the
plasma metabolomic profile.
Specific Aim 2: To identify the pathways involved in the differences in the plasma metabolites markers.
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CHAPTER 2: METHODOLOGY
2.1

Animals

24 in-bred Brown Norway (BN) rats were obtained from the aged rodent colonies of the National Institute
of Aging (Bethesda, MD). Upon arrival, 12 rats were 22 weeks old and 12 were 24 weeks old.
2.2

Housing and Husbandry

All the rats were accommodated in individual cages, in the same room. They were housed at Laboratory
Animal Resources (DLAR) facility under standard conditions. These conditions were approved by Wayne
State University Animal Investigation Committee (AIC). All the animals received alternating light
conditions with 12 hours of light and 12 hours of darkness, under normal humidity and at room temperature.
Cage bedding and water were replaced weekly and their health were monitored regularly.
2.3

Experimental protocol and diets

Prior to the start of scrutiny, all the animals were allowed to reconcile for a week. Ensuing the reconciliation
period, all the animals were randomly allotted in 4 different groups, with the constraint of same mean body
weight for all the diets groups. The groups were named as per the diet: Control diet (n=8), High Cholesterol
diet (n=8), High Cholesterol + Curcumin diet (n=8) and High Cholesterol + OPP (n=8). The diet
compositions are summarized in table 1. Isocaloric diet was provided to all the groups. The purified and
sufficient diets were obtained in pellets from Dyets Inc. (Bethlehem, PA), for the entire duration of the
study. The diets were kept at -20C and diet was taken weekly as needed and kept refrigerated at 4C.
Animals were fed ad libitum and had free access to water.
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Fig 6: The different groups of the animals based on the atherogenic diet
Control groups
C: Rats on standard purified diet.
Experimental groups
H: Rats on standard purified diet + 2% cholesterol;
HP: Rats on standard purified diet + 5% OPP + 2% cholesterol;
HC: Rats on standard purified diet + 2% Curcumin + 2% cholesterol.
2.4

Experimental Procedures
The table 2 summarizes the experimental procedures carried out for the study. All the rats were

provided with their respective diets for 23 weeks and had free access to water. Body weight and food intake
were recorded twice a week throughout the duration of the study. Upon completion of the study at week
23, each animal was anesthetized using carbon dioxide chamber and decapitated followed by
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exsanguination and tissue collection. Tissues were flash frozen in liquid nitrogen then stored at -80C until
ready to be used for analysis. Plasma was isolated and stored at -80ºC until ready to be used for analysis.
All procedures and protocols were in accordance with and ratified by the Animal Investigation Committee
of Wayne State University.
Table 2: Experimental procedures
Procedures
Body weight, diet intake, water intake
Urine collection
Plasma and tissue collection

Frequency of Measurement
Twice weekly (week 1-6)
Once weekly (Week 2,4,6)
End of study (Week 6)

Table 1: Composition of purified diets

Ingredient

Isocaloric Control

High Cho (2% Cholesterol) High Cho +5%OPP

High Cho+2% Curcumin

g/kg
Casein

140

140

140

140

L-Cystine

1.8

1.8

1.8

1.8

Sucrose

100

77.5

77.5

77.5

Cornstarch

465.692

465.692

415.692

445.692

Dyetrose

155

155

155

155

Soyabean oil

40

40

40

40

tbutylhydroquinone
Cellulose

0.008

0.008

0.008

0.008

50

50

50

50

Mineral
Mix#210050
Vitamin
Mix#310025
Choline Bitartrate

35

35

35

35

10

10

10

10

2.5

2.5

2.5

2.5

Cholesterol

_

20

20

20

Cholic Acid

_

2.5

2.5

2.5

OPP

_

_

50

_

Curcumin

_

_

_

20

Total

1000

1000

1000

1000

Calorie

3602

3512

3332

3440

Diets were prepared and pelleted by Dyets Inc. (Bethlehem, PA).
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Overall Study Design

Fig 7: The overall study design
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2.5

Sample preparation for NMR spectroscopy:
Plasma samples were thawed from -80C and equilibrated to room temperature. On the bases of

amount collected, samples were selected for NMR Spectroscopy. Total 20 samples were selected, and were
divided into group of 5 based on the diet. The grouping is as follows: Control (n=5), High Cholesterol diet
(n=5), High Cholesterol + Curcumin diet (n=5) and High Cholesterol + OPP (n=5).
2.6

NMR Spectroscopy:
Plasma samples from all the groups were analyzed on Varian 600S NMR Spectrometer (Varian

Inc, Palo Alto, CA, USA) at 600 MHz. The probe used was 5mm AutoX Dual broadband with variable
temperature capabilities. VNMRJ software was used. Console was multinuclear broadband system, pulse
field gradient and variable temperature compatible. ACD software (ACD Toronto, Ontario, Canada) was
used for proper processing of the spectra for subsequent multivariate analysis using SIMC P+ software
(Umetrics, Kinnelon, NJ). All the free induction decay (FID) files from NMR spectrometer were imported
at one time to the ACD software to avoid differences caused by spectral processing at different times. The
fid files were fourier transformed, baseline corrected and auto phased. Spectra were calibrated using DSS
peak as reference at 0 ppm (parts per million). Then Spectra were binned into group 1000 bins using
intelligent binning. We used intelligent binning to make sure that a single peak would not be split into
different bins. The table of integrals was exported to SIMCA P+ software for principal component analysis
(PCA). Binning divides the spectra into small regions and the table of integrals can be analyzed by
multivariate analysis as different variables.
2.7

Multivariate analysis:
Using SIMCA-P+ software, both multivariate pattern recognition techniques, unsupervised (principal

component analysis, PCA) and supervised (partial least-squares discriminant analysis, PLS-DA) were
employed to the data in order to discriminate sample spectra of different experimental groups. PCA is an
unsupervised mathematical algorithm. A principal component (PC) is weighted linear combination of each
of the original NMR variables so that the original data matrix is compressed into a smaller number of
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variables; normally NMR data is compressed into 3-4 PC’s. The weight given to each variable within a PC
describes how influential that variable is in relation to the other variables. We used PCA to examine inherent
clustering and correlations within the data. Spectral region 4.5-6 ppm from table of integrals was removed
prior to PCA analysis as this region contains water peaks and other aliphatic compound with exchangeable
protons. Pareto scaling was used to see the small changes in metabolite concentration between the two
groups. PCA is an unsupervised multivariate projection method designed to extract and display the systemic
variation in the data matrix X as a score plot. The corresponding loading plot provides information about
the part of the spectrum that is responsible for the similarities and/or dissimilarities in the data set as
observed in the score plot. PLS is a regression extension of PCA, which was used to connect the information
in two blocks of variables, X and Y, to each other. Moreover, regression analysis using orthogonal
projections to latent structures (OPLS) was also conducted on several investigated variables. Regression
analysis enables the evaluation of the relationship between urinary metabolite profiles with the variables
investigated independently of the metabolomic profiles. In PLS-DA the data set was distributed into classes
and its objective was to find a model that separated the classes of observation on the basis of their Xvariables, while using a hypothetical Y-variable. Both OPLS and PLS-DA methods of analysis are
supervised, which implies that some information about the data set is provided to the software prior to
analysis.
2.8

Metabolite identification and quantification:
The fid files from Varian 600S NMR spectrometer were imported to the CHENOMX suite

(CHENOMX INC, Edmonton, Alberta) for the measurement of the metabolite concentration. Imidazole
added in the preparation of samples was used as pH indicator and DSS as reference at 0 ppm. The spectra
were Fourier transformed and processed using the processor tool within the software. This included base
line correction; auto phasing and reference deconvolution. These processed files were analyzed in profiler
module of the software. The CHENOMX Profiler module uses targeted profiling where spectral binning or
spectral bucketing is not required. Targeted profiling is unique as it has the ability to analyze one compound
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selectively or selective peaks individually for the spectrum (Colin Vitols, Ryan Rosewell, Identifying
metabolites in biofluids, March 2006, CHENOMX publications).
Clusters can be selected for analysis (CHENOMX Publication). We used DSS as chemical shape
indicator. Peaks and clusters from the spectrum were fitted using 500 library which is essentially NMR
database of more than 250 metabolites. Concentrations of the metabolites were measured by fitting the
peaks in the sample spectrum to a reference spectrum by click and drag kind of interface. The compound
selected appeared as series of multiple dots on the spectrum, peak is fitted by dragging the arrows sideways.
In the area crowded with clusters, multiple compounds needed to be fitted to match the spectrum as closely
as possible. Calculation of the concentrations was based on the concentration of DSS, the chemical shape
indicator. Metabolic pathways for the metabolites identified were searched through KEGG ligand database.
2.9

Pathway Validation:
MetaboAnalyst3.0 software was used to explore the potential pathway. MetaboAnalyst software

utilizes pathway enrichment analysis and pathway topology analysis to translate metabolic trends into
defined pathways relevant to the study. MetaboAnalyst likewise bolsters various data analysis and data
representation errands utilizing a scope of univariate, multivariate techniques, for example, PCA (principal
component analysis), PLS-DA (partial least squares discriminant analysis), warm guide bunching and
machine learning strategies. MetaboAnalyst likewise offers an assortment of apparatuses for metabolomic
data translation including MSEA (metabolite set enrichment analysis), MetPA (metabolite pathway
analysis), and biomarker selection via ROC (receiver operating characteristic) curve analysis, and in
addition time arrangement and influence analysis. A .csv or .txt document is typically utilized when the
entire data set has already been pre-prepared to a tabular frame, for example, a compound concentration
table, a spectral bin table, or a peak force table. The compress record format is typically used to upload
numerous MS spectra or various peak list documents. Be that as it may, because of bandwidth constraints,
it is generally impractical to upload large spectral documents (> 50 MB) remotely to MetaboAnalyst.
Rather, raw spectra ought to be pre-prepared (peak picked and/or aligned) utilizing locally installed
software to create the necessary (and smaller) peak list documents or peak power tables before uploading
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to MetaboAnalyst. This pre-handling step can be finished by any number of locally installable,
uninhibitedly available MS spectral preparing instruments, for example, MetAlign (Lommen, 2009),
OpenMS (Sturm et al., 2008), MZmine
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CHAPTER 3: RESULTS
3.1 Survival of Rats
A sum of 32 maturing dark colored Norway rats were utilized for this investigation. Animals were
randomly appointed to 4 groups for a 23-week dietary intercession to research the in-vivo impact of OPP
on AD initiated by an atherogenic eating routine. At endpoint (week 23), each gathering had lost three
animals before the end of the examination because of death or conditions that requested an early
euthanization.
3.2 Body weight and diet intake:
No critical contrasts were seen among groups at baseline (week 1) and endpoint (week 23)
regarding mean body weight. For count calories consumption, normal eating routine admission (g) every
week (the aggregate eating routine admission amid the entire examination time frame/23 weeks) was
figured and thought about among four gatherings as opposed to contrasting the benchmark with endpoint
due with transforming from the office standard chow eating regimen to exploratory eating methodologies
at the gauge. Essentially, the methods for week after week eat less admission were not observed to be huge
between among four gatherings.
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Fig 8: Comparison of mean body weight in Control (C), High cholesterol (H), High cholesterol + 5% OPP
(HP) and High cholesterol + 2% curcumin (HC) at baseline (week 1) and endpoint (week 23). Data are
expressed as mean±SE. No significant differences between groups observed (p>0.05).
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Fig 9: Comparison of mean weekly diet intake in Control (C), High cholesterol (H), High cholesterol + 5%
OPP (HP) and High cholesterol + 2% curcumin (HC) over the whole feeding period. Data are expressed as
mean±SE. No significant differences between groups observed (p>0.05)
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3.3 NMR Spectroscopy and Multivariate analysis:
Plasma samples were selected based on the atherogenic diet. A minimum of 750 μl is required for
NMR spectroscopy, so we selected samples with at least one aliquot of 1ml. NMR spectroscopy was
performed on Varian 600s (at 600 MHZ) and the fid files were processed using ACD software (fig). The
processed NMR spectra were digitized and the table of integrals from ACD software was exported to
SIMCA P+ software for multivariate statistical analysis. The integrals corresponding to the NMR spectral
region from 4.5ppm to 6 ppm were removed from Principal Component Analysis (PCA) as this area
contains water peak and other metabolite with exchangeable protons before PCA. PCA score plot showed
clustering of one atherogenic diet group from other (fig 12). To observe the clear distinction, the supervised
method, OPLS DA plots were plotted.

Fig 10a. Fid file

Fig 10.b. Pre-processing of NMR
files by ACD software

23
Specific Aim 1A: To investigate differences in metabolomic profiles of Atherogenic Diet Induced Rat
Model of Alzheimer’s Disease (AD) and treatment with dietary OPP/ curcumin in Control (C), High
cholesterol (H), High cholesterol + 5% OPP (HP) and High cholesterol + 2% curcumin (HC)
Contrasts in the metabolomic profiles of aging rats subjected to various eating methodologies
(standard control diet, 2% high cholesterol diet, 2% high cholesterol diet+5% OPP diet, 2% high cholesterol
diet+2% curcumin diet) in this examination were assessed utilizing, 1H NMR (proton Nuclear Magnetic
Resonance spectroscopy). We aimed to look at possible differences in the plasma metabolomic profiles of
different diet groups, using multivariate analysis. The OPLS DA score plot (Fig 13) shows the separation
among all the four diet groups.

Fig 11: Multivariate analysis of four groups: The supervised method, PLSDA score plot based on plasma
1

H NMR spectra of rats of four groups with control, high cholesterol, high cholesterol + curcumin and high

cholesterol + OPP
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A.

B.

Fig 12A: Multivariate analysis of two groups: The OPLS DA score plot based on 1H NMR spectra of
rats of Control and high cholesterol group.
Fig 12B: Multivariate analysis of two groups: The loading plot depicting the spectral regions responsible
for separation between two diet groups at different ppm.

25
A.

B.

Fig 13A: Multivariate analysis of two groups: The OPLS DA score plot based on 1H NMR spectra of
rats of Control and high cholesterol + curcumin (Curcumin) group.
Fig 13B: Multivariate analysis of two groups: The loading plot depicting the spectral regions responsible
for separation between two diet groups at different ppm.
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A.

B.

Fig 14A: Multivariate analysis of two groups: The OPLS DA score plot based on 1H NMR spectra of
rats of Control and high cholesterol + OPP (OPP) group.
Fig 14B: Multivariate analysis of two groups: The loading plot depicting the spectral regions responsible
for separation between two diet groups at different ppm.
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A.

B.

Fig 15A: Multivariate analysis of two groups: The OPLS DA score plot based on 1H NMR spectra of
rats of High Cholesterol and high cholesterol + Curcumin (Curcumin) group.
Fig 15B: Multivariate analysis of two groups: The loading plot depicting the spectral regions responsible
for separation between two diet groups at different ppm.
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A.

B.

Fig 16A: Multivariate analysis of two groups: The OPLS DA score plot based on 1H NMR spectra of
rats of High Cholesterol and high cholesterol + OPP (OPP) group.
Fig 16B: Multivariate analysis of two groups: The loading plot depicting the spectral regions responsible
for separation between two diet groups at different ppm.
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A.

B.

Fig 17A: Multivariate analysis of two groups: The OPLS DA score plot based on 1H NMR spectra of
rats of High Cholesterol + Curcumin (Curcumin) and high cholesterol + OPP (OPP) groups
Fig 17B: Multivariate analysis of two groups: The loading plot depicting the spectral regions responsible
for separation between two diet groups at different ppm.
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Specific Aim 1B: To identify and quantify metabolites responsible for the differences in Metabolomic
Profiles of Control and treated groups.

1,3- dihydroxyacetone
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A : C – Control H- High Cholesterol, HC – High cholesterol + Curcumin, HP – High Cholesterol +OPP
a & b are significantly different from each other (p<0.05)
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Fig B: C – Control H- High Cholesterol, HC – High cholesterol + Curcumin, HP – High Cholesterol +OPP
a & b are significantly different from each other (p<0.05)
a & c are significantly different from each other (p<0.05)
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Fig C: C – Control H- High Cholesterol, HC – High cholesterol + Curcumin, HP – High Cholesterol +OPP
a & b are significantly different from each other (p<0.05)
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Fig D: C – Control H- High Cholesterol, HC – High cholesterol + Curcumin, HP – High Cholesterol +OPP
a & b are significantly different from each other (p<0.05)
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Fig E: C – Control H- High Cholesterol, HC – High cholesterol + Curcumin, HP – High Cholesterol +OPP
a & b are significantly different from each other (p<0.05)
c is significantly different from a & b (p<0.05)
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Fig F: C – Control H- High Cholesterol, HC – High cholesterol + Curcumin, HP – High Cholesterol +OPP
a & b are significantly different from each other (p<0.05)
c is significantly different from a & b (p<0.05)
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Fig G: C – Control H- High Cholesterol, HC – High cholesterol + Curcumin, HP – High Cholesterol +OPP
a & b are significantly different from each other (p<0.05)
c is significantly different from a & b (p<0.05)
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Fig H: C – Control H- High Cholesterol, HC – High cholesterol + Curcumin, HP – High Cholesterol +OPP
a & b are significantly different from each other (p<0.05)
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Fig I: C – Control H- High Cholesterol, HC – High cholesterol + Curcumin, HP – High Cholesterol +OPP
a & b are significantly different from each other (p<0.05) , c is significantly different from a & b (p<0.05)
Fig 18: Selected plasma metabolites associated with the diet effect found in Homocysteine

metabolism by the pathway analysis
Table 3. Changes in the metabolomic profile due to the diet effect
Compounds

Chemical

P value

Fisher's LSD post-hoc

<0.01

Control - Curcumin; Control - OPP; HighCho -

shift
2-Oxoglutarate

4.0 2.3 2.2 2.0
1.8

Melatonin

Curcumin; HighCho - OPP
<0.01

Curcumin - Control; Curcumin - HighCho; Curcumin OPP

4Hydroxyphenylacetate

7.2 6.9 3.4

<0.01

Curcumin - Control; Curcumin - HighCho; Curcumin OPP
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Catechol

6.9 7.0

<0.01

Curcumin - Control; Curcumin - HighCho; Curcumin OPP

dTTP

1.9 2.4 4.2 4.6

<0.01

6.3 7.7
Phenol

7.0 7.3 6.9

Curcumin - Control; OPP - Control; Curcumin HighCho

<0.01

Curcumin - Control; Curcumin - HighCho; Curcumin OPP

Acetoacetate

2.3 3.4

0.02

HighCho - Control; HighCho - Curcumin; HighCho OPP

Riboflavin

2.5 2.6 3.7 3.9

0.02

Control - HighCho; Control - OPP

4.0 4.4 5.0 8.0
Taurine

3.2 3.4

0.02

Control - Curcumin; Control - HighCho; Control - OPP

Allantoin

8.0 7.3 6.0 5.4

0.02

HighCho - Control; HighCho - Curcumin; HighCho OPP

Citrate

2.7 2.5

0.03

Control - Curcumin; Control - OPP

Serotonin

3.1 3.3 6.9 7.1

0.03

Curcumin - Control; Curcumin - HighCho

0.03

Curcumin - Control; Curcumin - HighCho; Curcumin -

7.3 7.4 10
Homoserine

2.0 2.2 3.8 3.9

OPP
Phthalate

7.5

0.03

Curcumin - Control; Curcumin - OPP

Theophylline

8.0 3.6 3.4

0.03

Curcumin - Control; Curcumin - HighCho; Curcumin OPP

Tyrosine

7.2 6.9 3.9 3.2

0.03

Curcumin - Control; Curcumin - HighCho

0.03

Control - Curcumin; HighCho - Curcumin; HighCho -

3
Ethanolamine

3.1 3.8

OPP
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N-Phenylacetylglycine

3.7 7.3 7.4 7.9

0.04

Curcumin - Control; Curcumin - HighCho; Curcumin OPP

Homocysteine

2.2 2.3 2.8 2.9

0.04

HighCho - Control; HighCho - Curcumin

0.04

HighCho - Control; HighCho - Curcumin; HighCho -

3.9
3-hydroxybutyrate

1.2 2.3 2.4 4.1

OPP
Trimethylamine

2.9

0.04

HighCho - Curcumin; HighCho - OPP

Gentisate

6.8 7.0 7.3

0.04

HighCho - Control; HighCho - Curcumin; HighCho OPP

Serine

4.0 3.9 3.8

0.04

HighCho - Control

The relationship between plasma metabolite profiles with some of the variables that is related to
the AD progression such as hippocampal βamyloid 42 concentration, brain oxidative stress and peripheral
inflammation(Il-6) were also performed by regression analysis. As seen from the fig. 29, OPLS regression
shows moderate correlation (R²=0.5276) between peripheral inflammation and plasma NMR metabolomic
profile. Similarly, the OPLS regression plot between hippocampus βAmyloid 42 concentration (fig.30) with
plasma 1H NMR profiles of the four groups at end time point shows a moderate correlation too (R²= 0.5765).
The S-plot obtained from OPLS model at endpoint indicates the regions of the metabolites that are
respectively positively and negatively correlated with the IL-6. There is a moderate correlation (R²= 0.5141)
between brain oxidative stress level (MDA) with plasma 1H NMR profiles of the four groups at end time
point (fig. 30). The S-plot shows the respective positive and negative co relation between brain oxidative
stress level (MDA) and plasma metabolomic profile.
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A.

B.

Fig.19: OPLS regression of brain oxidative stress level (MDA) with plasma 1H NMR profiles of the

four groups at end time point. (A) OPLS score shows a moderate correlation (R2=0.5141) at endpoint
(week 22). (B) S-plot obtained from OPLS model. The circle on the upper right side includes the regions
of metabolites in the spectra that is correlated with higher MDA level; Regions containing regions of the
metabolites are circled at lower left side are correlated lower MDA level.
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Fig 20. OPLS regression of plasma inflammation level (IL-6) with plasma 1H NMR profiles of the four

groups at end time point. (A) OPLS score shows a moderate correlation (R2=0.5276) at (week 22). (B)
S-plot obtained from OPLS model. The circle on the upper right side includes the regions of metabolites in
the spectra that is correlated with higher higher Il-6 level; Regions containing regions of the metabolites
are circled at lower left side are correlated lower Il-6 level.
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A.

B.

Fig 21. OPLS regression of hippocampus βAmyloid 42 concentration with plasma 1H NMR profiles

of the four groups at end time point. (A) OPLS score shows a moderate correlation (R2=0.5765) at
endpoint (week 22). (B) S-plot obtained from OPLS model. The circle on the upper right side includes the
regions of metabolites in the spectra that is correlated with higher βAmyloid 42 concentration; Regions
containing regions of the metabolites are circled at lower left side are correlated lower βAmyloid 42
concentration.
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Specific Aim 2: To identify the pathways involved in the differences in the plasma metabolites markers.
Pathway analysis was performed using the software Metaboanalyst 3.0. The. exl file was converted
to .csv file, as the software can accept only comma separated file. A .csv or .txt document is typically
utilized when the entire data set has already been pre-prepared to a tabular shape, for example, a compound
concentration table, a spectral bin table, or a peak force table. The compress document format is typically
used to upload different MS spectra or numerous peak list records. The file is further processed and
normalized to obtain the pathway. Fig. 32 depicts the impacted pathway and their network analysis. The
significant pathway observed in this analysis is Cysteine-Methionine Metabolism and Glycine, serine,
taurine Metabolism. The fig 23-25 depicts the changes in the metabolites leading to the significant change
in the Cysteine-Methionine Metabolism.
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Glycine, serine, taurine Metabolism

Cysteine-Methionine
Metabolism

Sphingolipid
metabolism

Aminoacyl t-RNA biosynthesis

Methane Metabolism

Taurine and hypotaurine metabolism

Primary bile acid
synthesis
Nitrogen Metabolism

Glutathione Metabolism

Pyrimidine
Metabolism
Citrate
cycle

Fig 22. Pathway analysis.

Tryptophan Metabolism
glycolysis

MetaboAnalyst 3.0 output illustrating the most predominant metabolic

pathways that correspond to the significant metabolites changed in the plasma metabolomic profiles. The
larger a circle and higher on the y axis, the higher impact of pathway.
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CHAPTER 4: DISCUSSION
Homocysteine is a non-protein α-amino corrosive. It is a homologue of the amino corrosive
cysteine, differing by an extra methylene connect. It is biosynthesized from methionine by the expulsion of
its terminal Cε methyl gathering.

Fig 23: Structure of Homocysteine[28]

Mechanisms by which HCY influences AD are obscure. Be that as it may, deleterious mechanisms
involving HCY have been studied with regards to cardiovascular disease. Because of a growing
acknowledgment that cerebrovascular disease may advance AD, ideas taken from studies of HCY and
coronary illness research are being stretched out to the brain. For instance, plasma HCY might be
specifically harmful to vascular endothelial cells or induce their dysfunction, leading to loss of blood-brainbarrier work and changed generation of nitric oxide. What's more, if HCY crosses the blood-brain barrier
or is released by cells in the brain, it would act be able to as a powerful neurotoxin HCY levels anticipated
the incidence of AD and different dementias even after adjustment for known risk factors of age, sex, and
hereditary type of apoE. This work is essential for several reasons. First, this study is prospective in nature,
and results have prescient esteem. A substantial number of individuals were included, and, notwithstanding
HCY, metabolic parameters identified with HCY were evaluated. Second, the quantity of epidemiologic
studies addressing the part of HCY in AD and different dementias is few, and further work, such as that
done by Seshadri and colleagues, is required using all around defined populations. Finally, because levels
of homocysteine can be balanced by dietary folate, this study pinpoints a potential focus for AD
counteractive action. Such neurotoxic effects might be because of direct interaction of HCY with plasma
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film components, or because of intracellular aggregation of S-adenosyl-homocysteine. This last metabolite
inhibits methylation of catechol substrates resulting in the era of oxyradicals and other synthetically
responsive products that are cytotoxic. In general, HCY may harm brain tissue through different pathways,
which are yet unidentified[29].

Fig 24: Cysteine-Methionine Pathway[30]

The research data till now suggests that AD is the most common form of neurodegenerative
disorder. In its sporadic shape, AD results from the blend of hereditary components with various
epigenetic occasions. The diagnosis of AD is usually based on the symptoms that occurs after the
age of 65. The research shows some neurotic components that have recently been found in the
brain before the manifestations show up, which make the patient lose the most obvious opportunity
for early determination and treatment of AD. Therefore, animal models have been produced and
connected to illustrate the AD obsessive movement and systems. There is an expanding
consciousness that way of life particularly a high fat/cholesterol slim down is assuming a negative
part to cardiovascular capacity, tumor rates, and cognitive function. A study by Granholm AC, et.
Al revealed that diet rich in cholesterol and/or saturated fats is deleterious to cognitive function.
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They fed 16-month old rats, cholesterol (2%) and saturated fat (hydrogenated coconut oil, Sat Fat
10%) diet for two months to investigate the impacts on memory of the rats, thus suggesting,
cholesterol can immensely impair memory[31]. The lipid profiles revealed elevated total
cholesterol levels. In our present study, when we performed multivariate analysis using SIMCA
p+ software, it exhibited the separation between different diet groups, at 3.14, 3.15, 3.32, 3.55,
3.56, 3.57 ppm. The further analysis was done to identify and quantify these metabolites involved
using CHENOMX and t-test to obtain the significantly different metabolites. Snowden, et al.,
applied untargeted metabolomics to the brain tissue collected by autopsy from three different
groups, AD, control and asymptomatic Alzheimer’s disease to study difference in brain metabolite
levels. They analyzed the center frontal gyrus, inferior temporal gyrus and the cerebellum (CB),
which is generally saved of established AD pathology. They found that unsaturated fatty acids
were significantly decreased in Alzheimer's brains when compared to brains from healthy patients
and DHA, increased with the progression of the disease[32]. Similarly, our results (fig 20) showed
increased level of 1,3-Dihydroxyacetone in the high cholesterol fed diet, thus indicating the
dementia. A current report announced by Schernthaner, that ketoacidosis autonomously instigated
changes in pro inflammatory cytokines, oxidative stress and CVD as large amounts of circulating
IL-6 and TNF-α were lifted in hyperketonemic diabetics yet not in ordinary diabetic patients[33].
Ketones such as acetoacetate (AA) has been reported to increase cellular lipid peroxidation
resulting from oxygen radical production by AA or other effects of AA on enzymes or signal
transduction pathways that in turn lead to elevated oxidative stress. The oxygen radicals generated
by the ketone body acetoacetate can exert cytotoxic effect by causing peroxidation of membrane
phospholipids and the resulting accumulation of peroxidation products such as malondialdehyde
(MDA). These products have been known to cross-link membrane components and result in altered
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membrane permeability and an ultimate cellular dysfunction[34]. The ketones such as acetoacetate
and acetate were also found to be high in our high cholesterol fed diet animals (fig 21, 22) thus
reflecting high oxidative stress. The level of these ketones was significantly reduced by curcumin
and OPP fed diet. Thus, demonstrating the antioxidant and anti-inflammatory effect on the ketones
in the plasma. This is in accordance with another study by Li et al. [35]who showed that curcumin
administration significantly reduced ketone body levels in mice fed high fat diet. In conclusion,
supplementation with OPP and curcumin reduces oxidation-induced ketone generation and
attenuates the atherosclerosis events in rats fed a high cholesterol diet. One of the pathway with
high significance and impact in rat’s plasma profile is Homocysteine metabolism. Some
metabolites from its metabolism were significantly higher in the cholesterol fed animals as
compared to the control group. Treatment with curcumin and OPP brought down the concentration
of these metabolites significantly and closer to the control levels. Significant effects were observed
in serine, cysteine, methionine in the curcumin diet groups A scope of mechanisms having been
proposed for the connection between elevated Homocysteine (Hcy) and AD and preclinical
investigations demonstrate that hyperhomocysteinemia, initiated by hereditary control or by Bvitamin insufficiency, causes referred to signs of AD, for example, aggregation of amyloid-β
peptide[36]. A post-mortem examination demonstrated a clear association between Hcy levels and
neurofibrillary tangles, a known sign of AD[37]. Amyloid plaque arrangement is believed to be an
imperative occasion in the etiology of AD and there is affirmation that raised levels of Hcy can
affect the plaque development by lessening the clearing rate of amyloid-β in the mind of mice and
can induce oxidative stress[38]. Amyloid-β levels increased in rats after infusion of Hcy into their
mind along with loss in spatial memory[39]. In accordance, we found significantly high level of
homocysteine in the high cholesterol fed diet animal thus indicating Alzheimer’s Disease. But, on
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the other side, the level of homocysteine was significantly decreased in the High Cholesterol +
Curcumin fed diet animal (fig 24).
To verify the results further, the correlation plot was plotted between the plasma
metabolomic profile and lipid oxidation indicator, inflammation marker (IL-6) and amyloid plaque
deposition. All the correlation plot (Fig 29, 30, 31) showed more than 50% significance. Thus,
suggesting that the data is strongly correlated.
In conclusion, curcumin and OPP have anti-inflammatory and anti-oxidative effect on the
atherogenic diet induced rat models. Observations from this study can be further investigated using
larger scale animal studies that may lead to a pilot human study. Some findings from the plasma
metabolomic profiles might provide a potential pharmaceutical / nutraceutical target for the future
AD treatment.
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ABSTRACT
THE EFFECT OF OIL PALM PHENOLICS (OPP) AND CURCUMIN ON PLASMA
METABOLOMIC PROFILE IN ATHEROGENIC DIET INDUCED RAT MODEL OF
ALZHEIMER’S DISEASE (AD)
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Alzheimer's disease (AD) is the most widely recognized reason for dementia in
the aging population. It is described by intellectual decay and deposition of ß-amyloid plaques in
the hippocampus. It has been demonstrated that hypercholesterolemia incited by elevated
cholesterol abstain from food is related with AD advancement. Expanded level of oxidative stress
has additionally been seen in AD patients. An essential methodology to treat or postpone the
disability depends on dietary change, utilizing nourishment supplements. OPP, a water-soluble
fraction from oil palm fruit, rich in phenolics has been found to possess significant antioxidant
activities. Curcumin, a polyphenol extricated from the plant Curcuma longa, has demonstrated its
remedial advantages in Alzheimer's ailment and was utilized as a positive control. Our results
demonstrated the dietary cholesterol actuated hypercholesterolemia which expanded AD-like
pathological changes in matured rats including β-amyloid amassing and psychological decrease.
OPP & curcumin attenuate the process of AD for their antioxidant and anti-inflammatory effects
by improving these pathological changes. acquire the spectrum of samples. Multivariate analysis
software, SIMCA-P+, was applied to demonstrate the differences in plasma 1H NMR profiles
among the groups. Partial least Squares (PLS-DA) score plots showed clear separation among all
four groups indicating differences in their metabolomics profiles at the end point. OPLS regression
analysis gave significant correlations between the urinary metabolomic profiles and the β amyloid
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burden. The metabolites responsible for the differences in the metabolomic profile among groups
were then quantified using CHENOMX NMR metabolite database. Some metabolites from the
homocysteine metabolism pathway were significantly altered in the cholesterol fed group (H) as
compared to the treatment groups (HP, HC). Treatment with curcumin (HC) or OPP (HP)
modulated the concentration of these metabolites closer to the control levels. This pathway has
been shown to be perturbed in neurodegenerative diseases. Taken together, curcumin exhibited a
potential therapeutic effect in high cholesterol diet induced AD. Moreover, specific plasma
metabolites may serve as non-invasive biomarkers for progression of neurodegenerative diseases
including AD.
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